Augmentin and Duricef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Duricef (cefadroxil/cefadroxil hemihydrate). Common drug interactions include drug hypersensitivity among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Duricef. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Duricef?

Duricef has active ingredients of cefadroxil/cefadroxil hemihydrate. eHealthMe is studying from 579 Duricef users. Check the latest studies of Duricef.

On Jul, 13, 2026

16 people who take Augmentin and Duricef together, and have interactions are studied.

Augmentin and Duricef drug interactions.

What are the common drug interactions of Augmentin and Duricef, by gender? *:

female:

Drug hypersensitivity
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Anaemia (lack of blood)
Anaemia postoperative
Angina pectoris (chest pain due to ischemia of the heart muscle)
Anxiety
Blood creatinine increased
Carbon dioxide increased
Cardiac failure congestive
Cerebral infarction (less blood supply to brain resulting tissue damage)

male:

Cellulitis (infection under the skin)
Postoperative wound complication
Drug level increased
Dysuria (painful or difficult urination)
Enterobiasis (intestinal infection caused by the parasitic roundworm called enterobius vermicularis)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Otitis externa (external ear infection)
Otitis media (inflammation of the middle ear)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

What are the common drug interactions of Augmentin and Duricef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Arrhythmia (irregular heartbeat)
Sudden death
Unresponsive to stimuli
Vomiting
Abdominal pain
Drug level increased
Dysuria (painful or difficult urination)
Enterobiasis (intestinal infection caused by the parasitic roundworm called enterobius vermicularis)
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia postoperative
Angina pectoris (chest pain due to ischemia of the heart muscle)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Cerebrovascular disorder (disease of brain)
Chest pain
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Haematuria (presence of blood in urine)
Herpes simplex (herpes simplex is a common viral infection)
Hyperlipidaemia (presence of excess lipids in the blood)
Obesity (having too much body fat)

50-59:

Arthralgia (joint pain)
Drug hypersensitivity
Hyperhidrosis (abnormally increased sweating)
Inflammation
Productive cough
Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
Skin exfoliation (removal of the oldest dead skin cells)

60+:

Cellulitis (infection under the skin)
Hypotension (abnormally low blood pressure)
Depression
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Dyspnoea exertional (breathlessness or shortness of breath)
Electrolyte imbalance
Fluid overload (too much fluid in the blood)
Fluid retention (an abnormal accumulation of fluid in the blood)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 31.25%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 18.75%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 18.75%
Prostate Cancer: 3 people, 18.75%
Diabetes: 3 people, 18.75%
Dyspnea (difficult or laboured breathing): 3 people, 18.75%
Oropharyngeal Pain: 3 people, 18.75%
High Density Lipoprotein Decreased: 3 people, 18.75%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 12.50%
Depression: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Duricef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously